Comparing Buprenorphine vs Tapentadol
| Buprenorphine | Tapentadol |
|
|---|
| Buprenorphine | Tapentadol |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Buprenorphine is a potent analgesic that should be only used to treat moderate to severe pain or for the treatment of opioid addiction under strict conditions. Different formulations of the drug... View more |
Prescription only
Prescribed for Diabetic Peripheral Neuropathy, Pain. Tapentadol may also be used for purposes not listed in this medication guide. |
||||||||
| More about Buprenorphine | More about Tapentadol | ||||||||
| Ratings & Reviews | |||||||||
|
Buprenorphine has an average rating of 6.7 out of 10 from a total of 1154 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 25% reported a negative effect. |
Tapentadol has an average rating of 6.4 out of 10 from a total of 436 ratings on Drugs.com. 54% of reviewers reported a positive effect, while 27% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Buprenorphine side effects |
View all Tapentadol side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
Lower cost generic |
N/A |
||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Buprenorphine prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
N/A |
||||||||
| Brand Names | |||||||||
| Belbuca, Brixadi, Buprenex, Butrans, Sublocade | Nucynta, Nucynta ER | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
48 hours |
4 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
High potential for abuse
Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
||||||||
| Pregnancy Category | |||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 726 drugs are known to interact with Buprenorphine:
|
A total of 422 drugs are known to interact with Tapentadol:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
|
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
December 29, 1981 |
November 20, 2008 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
|||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.